Education
About Us
Working with TipRanks
Follow Us
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
Total Valuation
Pharma Bio Services has a market cap or net worth of $13.39M. The enterprise value is $10.17M.
Market Cap$13.39M
Enterprise Value$10.17M
Share Statistics
Pharma Bio Services has 22,904,491 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,904,491
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharma Bio Services’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -5.34%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-5.34%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee120.01K
Profits Per Employee-1.34K
Employee Count75
Asset Turnover0.66
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pharma Bio Services is ―. Pharma Bio Services’s PEG ratio is 1.42.
PE Ratio―
PS Ratio1.38
PB Ratio1.04
Price to Fair Value1.04
Price to FCF-55.94
Price to Operating Cash Flow0.06
PEG Ratio1.42
Income Statement
In the last 12 months, Pharma Bio Services had revenue of 9.00M and earned -100.46K in profits. Earnings per share was >-0.01.
Revenue9.00M
Gross Profit2.91M
Operating Income-637.66K
Pretax Income-94.26K
Net Income-100.46K
EBITDA134.81K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 236.07M and capital expenditures -4.61K, giving a free cash flow of 236.07M billion.
Operating Cash Flow236.07M
Free Cash Flow236.07M
Free Cash Flow per Share10.31
Dividends & Yields
Pharma Bio Services pays an annual dividend of $0.075, resulting in a dividend yield of ―
Dividend Per Share$0.075
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.19
52-Week Price Change13.84%
50-Day Moving Average0.55
200-Day Moving Average0.56
Relative Strength Index (RSI)55.37
Average Volume (3m)2.53K
Important Dates
Pharma Bio Services upcoming earnings date is Mar 12, 2026, TBA (Confirmed).
Last Earnings DateJan 29, 2026
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
Pharma Bio Services as a current ratio of 7.70, with Debt / Equity ratio of 0.24%
Current Ratio7.70
Quick Ratio7.70
Debt to Market Cap0.00
Net Debt to EBITDA-24.85
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pharma Bio Services has paid 6.20K in taxes.
Income Tax6.20K
Effective Tax Rate-0.07
Enterprise Valuation
Pharma Bio Services EV to EBITDA ratio is 67.06, with an EV/FCF ratio of -40.81.
EV to Sales1.00
EV to EBITDA67.06
EV to Free Cash Flow-40.81
EV to Operating Cash Flow-42.07
Balance Sheet
Pharma Bio Services has $10.85M in cash and marketable securities with $28.83K in debt, giving a net cash position of $10.83M billion.
Cash & Marketable Securities$10.85M
Total Debt$28.83K
Net Cash$10.83M
Net Cash Per Share$0.47
Tangible Book Value Per Share$0.52
Margins
Gross margin is 29.27%, with operating margin of -7.08%, and net profit margin of -1.12%.
Gross Margin29.27%
Operating Margin-7.08%
Pretax Margin-1.05%
Net Profit Margin-1.12%
EBITDA Margin1.50%
EBIT Margin-1.05%
Analyst Forecast
The average price target for Pharma Bio Services is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-14.75%
EPS Growth Forecast89.89%